130 related articles for article (PubMed ID: 36329288)
1. TSPO PET signal using [
Quach S; Holzgreve A; Kaiser L; Unterrainer M; Dekorsy FJ; Nelwan DV; Bartos LM; Kirchleitner SV; Weller J; Weidner L; Niyazi M; Ruf VC; Herms J; Stöcklein S; Wetzel C; Riemenschneider MJ; V Baumgarten L; Thon N; Brendel M; Rupprecht R; Bartenstein P; Tonn JC; Albert NL
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):859-869. PubMed ID: 36329288
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma.
Albert NL; Nelwan DV; Fleischmann DF; Quach S; von Rohr K; Kaiser L; Teske N; Unterrainer LM; Bartos LM; Ruf VC; Brendel M; Riemenschneider MJ; Wetzel C; Herms J; Rupprecht R; Thon N; Tonn JC; Belka C; Bartenstein P; von Baumgarten L; Niyazi M; Unterrainer M; Holzgreve A
J Nucl Med; 2023 Oct; 64(10):1519-1525. PubMed ID: 37536737
[TBL] [Abstract][Full Text] [Related]
3. Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [
Kaiser L; Quach S; Zounek AJ; Wiestler B; Zatcepin A; Holzgreve A; Bollenbacher A; Bartos LM; Ruf VC; Böning G; Thon N; Herms J; Riemenschneider MJ; Stöcklein S; Brendel M; Rupprecht R; Tonn JC; Bartenstein P; von Baumgarten L; Ziegler S; Albert NL
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2371-2381. PubMed ID: 38396261
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of anti-3-[
Karlberg A; Pedersen LK; Vindstad BE; Skjulsvik AJ; Johansen H; Solheim O; Skogen K; Kvistad KA; Bogsrud TV; Myrmel KS; Giskeødegård GF; Ingebrigtsen T; Berntsen EM; Eikenes L
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):496-509. PubMed ID: 37776502
[TBL] [Abstract][Full Text] [Related]
5. Exploring the mechanism of 18F-fluorodopa uptake in recurrent high-grade gliomas: A comprehensive histomolecular-positron emission tomography analysis.
Cobes N; Tran S; Mathon B; Nichelli L; Bielle F; Touat M; Kas A; Rozenblum L
Eur J Neurol; 2024 Jan; 31(1):e16093. PubMed ID: 37823694
[TBL] [Abstract][Full Text] [Related]
6. Detection of recurrent high-grade glioma using microstructure characteristics of distinct metabolic compartments in a multimodal and integrative 18F-FET PET/fast-DKI approach.
Lohmeier J; Radbruch H; Brenner W; Hamm B; Hansen B; Tietze A; Makowski MR
Eur Radiol; 2024 Apr; 34(4):2487-2499. PubMed ID: 37672058
[TBL] [Abstract][Full Text] [Related]
7.
Patel CB; Fazzari E; Chakhoyan A; Yao J; Raymond C; Nguyen H; Manoukian J; Nguyen N; Pope W; Cloughesy TF; Nghiemphu PL; Czernin J; Lai A; Ellingson BM
J Neurooncol; 2018 Sep; 139(2):399-409. PubMed ID: 29679199
[TBL] [Abstract][Full Text] [Related]
8. Combination of pre-treatment dynamic [
Li Z; Holzgreve A; Unterrainer LM; Ruf VC; Quach S; Bartos LM; Suchorska B; Niyazi M; Wenter V; Herms J; Bartenstein P; Tonn JC; Unterrainer M; Albert NL; Kaiser L
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):535-545. PubMed ID: 36227357
[TBL] [Abstract][Full Text] [Related]
9. Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using
Lohmeier J; Radbruch H; Brenner W; Hamm B; Tietze A; Makowski MR
J Nucl Med; 2023 Nov; 64(11):1683-1689. PubMed ID: 37652542
[TBL] [Abstract][Full Text] [Related]
10. Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma.
Tang D; Nickels ML; Tantawy MN; Buck JR; Manning HC
Mol Imaging Biol; 2014 Dec; 16(6):813-20. PubMed ID: 24845529
[TBL] [Abstract][Full Text] [Related]
11. Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages.
Weidner L; Lorenz J; Quach S; Braun FK; Rothhammer-Hampl T; Ammer LM; Vollmann-Zwerenz A; Bartos LM; Dekorsy FJ; Holzgreve A; Kirchleitner SV; Thon N; Greve T; Ruf V; Herms J; Bader S; Milenkovic VM; von Baumgarten L; Menevse AN; Hussein A; Sax J; Wetzel CH; Rupprecht R; Proescholdt M; Schmidt NO; Beckhove P; Hau P; Tonn JC; Bartenstein P; Brendel M; Albert NL; Riemenschneider MJ
Acta Neuropathol Commun; 2023 Sep; 11(1):147. PubMed ID: 37697350
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and robustness of dynamic
Debus C; Afshar-Oromieh A; Floca R; Ingrisch M; Knoll M; Debus J; Haberkorn U; Abdollahi A
Sci Rep; 2018 Oct; 8(1):14760. PubMed ID: 30283013
[TBL] [Abstract][Full Text] [Related]
13. Imaging of the glioma microenvironment by TSPO PET.
Zinnhardt B; Roncaroli F; Foray C; Agushi E; Osrah B; Hugon G; Jacobs AH; Winkeler A
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):174-185. PubMed ID: 33721063
[TBL] [Abstract][Full Text] [Related]
14. [PET/CT with 11C-methionine in assessment of brain glioma metabolism].
Vikhrova NB; Kalaeva DB; Tyurina AN; Belyaev AY; Danilov GV; Pronin IN
Zh Vopr Neirokhir Im N N Burdenko; 2024; 88(1):63-69. PubMed ID: 38334732
[TBL] [Abstract][Full Text] [Related]
15. Microglial Imaging in Alzheimer's Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study.
Yang Z; Banks SJ; Ritter AR; Cummings JL; Sreenivasan K; Kinney JW; Caldwell JK; Wong CG; Miller JB; Cordes D
J Alzheimers Dis; 2023; 96(4):1505-1514. PubMed ID: 37980664
[TBL] [Abstract][Full Text] [Related]
16. Predicting IDH genotype in gliomas using FET PET radiomics.
Lohmann P; Lerche C; Bauer EK; Steger J; Stoffels G; Blau T; Dunkl V; Kocher M; Viswanathan S; Filss CP; Stegmayr C; Ruge MI; Neumaier B; Shah NJ; Fink GR; Langen KJ; Galldiks N
Sci Rep; 2018 Sep; 8(1):13328. PubMed ID: 30190592
[TBL] [Abstract][Full Text] [Related]
17. The 18-kDa mitochondrial translocator protein in human gliomas: an 11C-(R)PK11195 PET imaging and neuropathology study.
Su Z; Roncaroli F; Durrenberger PF; Coope DJ; Karabatsou K; Hinz R; Thompson G; Turkheimer FE; Janczar K; Du Plessis D; Brodbelt A; Jackson A; Gerhard A; Herholz K
J Nucl Med; 2015 Apr; 56(4):512-7. PubMed ID: 25722450
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[
Tang D; Li J; Nickels ML; Huang G; Cohen AS; Manning HC
Mol Imaging Biol; 2019 Feb; 21(1):113-121. PubMed ID: 29869061
[TBL] [Abstract][Full Text] [Related]
19. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis.
Xiong M; Chen Z; Zhou C; Yang X; Hu W; Jiang Y; Zheng R; Fan W; Mou Y; Lin X
Recent Pat Anticancer Drug Discov; 2024; 19(3):383-395. PubMed ID: 38214322
[TBL] [Abstract][Full Text] [Related]
20. [¹¹C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches.
Su Z; Herholz K; Gerhard A; Roncaroli F; Du Plessis D; Jackson A; Turkheimer F; Hinz R
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1406-19. PubMed ID: 23715902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
